Related Experiment Video

Updated: Jul 8, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity

Megumi Funakoshi-Tago1, Stéphane Pelletier, Hiroshi Moritake

  • 1Department of Biochemistry, D4013, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, Tennessee 38105, USA.

Molecular and Cellular Biology
|December 28, 2007
PubMed

Insights

Janus kinase 2 (Jak2) constitutive activation, observed in the Y613E mutant, requires receptor binding but not Epo stimulation. This suggests receptor interaction relieves Jak2

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Janus kinases (JAKs) are crucial for cytokine receptor signal transduction.
  • Dysregulated JAK activity can lead to hematopoietic disorders and cancer.
  • Understanding JAK regulation is vital for controlling these diseases.

Purpose of the Study:

  • To identify phosphorylation events regulating Janus kinase 2 (Jak2) activity during EpoR signaling.
  • To characterize a constitutively active Jak2 mutant (Jak2-Y613E) and an inactivating mutant (Y766E).

Main Methods:

  • Genetic screening to identify mutations affecting Jak2 activity.
  • Analysis of Jak2 mutant properties in the context of EpoR signaling.
  • Investigating the role of receptor binding and Epo stimulation in Jak2 activation.

Main Results:

  • A Jak2 mutant (Y613E) was identified with constitutive activation, mimicking effects of other activating mutations (V617F, L611S).
  • Unlike V617F or L611S, the Y613E mutant requires receptor presence, not Epo stimulation, for activation and signaling.
  • The Y766E mutation was identified as inactivating.

Conclusions:

  • Jak2 is maintained in an inactive state when not associated with a receptor.
  • Receptor binding, potentially via the FERM domain, alleviates steric constraints, enabling Jak2 activation upon receptor engagement.
  • These findings provide insights into the regulatory mechanisms of Jak2 activation.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...